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ABSTRACT
It is increasingly common to combine Microarray
and Quantitative Trait Loci data to aid the search for
candidate genes responsible for phenotypic varia-
tion. Workflows provide a means of systematically
processing these large datasets and also represent
a framework for the re-use and the explicit declara-
tion of experimental methods. In this article, we
highlight the issues facing the manual analysis of
microarray and QTL data for the discovery of
candidate genes underlying complex phenotypes.
We show how automated approaches provide a
systematic means to investigate genotype–pheno-
type correlations. This methodology was applied to
a use case of resistance to African trypanosomiasis
in the mouse. Pathways represented in the results
identified Daxx as one of the candidate genes within
the Tir1 QTL region. Subsequent re-sequencing in
Daxx identified a deletion of an amino acid, identi-
fied in susceptible mouse strains, in the Daxx–p53
protein-binding region. This supports recent experi-
mental evidence that apoptosis could be playing a
role in the trypanosomiasis resistance phenotype.
Workflows developed in this investigation, including
a guide to loading and executing them with
example data, are available at http://workflows.
mygrid.org.uk/repository/myGrid/PaulFisher/.
INTRODUCTION
The process of linking genotype and phenotype plays a
crucial role in understanding the biological processes that
contribute to overall cellular, tissue and organism
responses, particularly when under a disease state (1,2).
The ﬁrst and classic example was the discovery of the
Huntington gene (3), which enabled predictive tests for
age of onset and severity of disease to be established. Since
then researchers have discovered single-gene lesions for a
large number of simple Mendelian traits. It has proved
much more diﬃcult, however, to discover genes under-
lying genetically complex traits which have continuous
rather than discrete variation in the phenotype (4), since
continuous variation is generally a product of small
contributions from multiple genes. Over 2000 Quantative
Trait Loci (QTL) have been mapped in mice and rats, yet
<1% of these have been characterized at the molecular
level (5).
The DNA polymorphism(s) underlying a QTL may be
in an exon, which subsequently changes the primary
amino acid structure of the gene. In other cases the
polymorphism may lie in a regulatory region, possibly
several kilobases from the transcription start site, altering
the regulation of gene expression or splicing. Tens to
hundreds of genes may be under even well-deﬁned QTL.
It is therefore vital that the identiﬁcation, prioritization
and functional testing of the polymorphisms identiﬁed in
relation to the Quantitative Trait gene (QTg) and
phenotype are carried out systematically without bias
introduced from prior assumptions about candidate genes
(4). With the advent of microarrays, researchers are able
to directly examine the expression of all genes under a
QTL and hence examine the eﬀect of regulatory variation
directly. This has made it possible to use expert knowledge
of the pathways underlying the phenotype to identify a
limited number of strong candidate genes (6).
The scale of data being generated by such high-
throughput experiments has led some investigators to
follow a hypothesis-driven approach (7), where the triage
and selection of candidate genes is based on some prior
knowledge or assumption. For example de Buhr et al. (6)
selected candidate genes based on their known
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techniques for candidate gene identiﬁcation can detect
QTg, they run the risk of overlooking genes that have less
obvious associations with the phenotype (8).
The complexity of multigenic traits can also lead to
problems when attempting to identify the varied processes
involved in the phenotype. For example numerous
processes can be involved in the control of parasitic
infection, including the ability of the host to kill the
parasite, mounting an appropriate immune response, or
control of host or parasite induced damage. By making
selections based on prior assumptions of what processes
may be involved, the pathways, and therefore genes, that
may actually be involved in the phenotype can be
overlooked or missed entirely.
In order to investigate whether such bias could be found
within current analysis techniques, we conducted a review
of the literature on combined QTL and microarray
analyses. This detailed review is available within the
Supplementary Data (Supplementray Table 2). Results
from this review enabled us to identify the speciﬁc issues
facing the manual analysis of microarray and QTL data,
including the selection of candidate genes and pathways.
These are listed below:
(i) Premature ﬁltering of datasets to reduce the amount
of information requiring investigation
(ii) Predominantly hypothesis-driven investigations
instead of a complementary hypothesis and data-
driven analysis
(iii) User bias introduced on datasets and results,
leading to single-sided, expert-driven hypotheses
(iv) Implicit data analysis methodologies
(v) Constant ﬂux of data resources and software
interfaces hinder reproducing searches and
re-analysis of data
(vi) Error proliferation from any of the listed issues
A further complication is that the use of ad hoc methods
for candidate gene identiﬁcation are inherently diﬃcult to
replicate and are compounded by poor documentation of
the methods used to generate and capture the data from
such investigations in published literature (9). An example
is the widespread use of ‘link integration’ (10) in
bioinformatics. This process of hyperlinking through any
number of data resources further exacerbates the problem
of capturing the methods used for obtaining in silico
results since it is often diﬃcult to identify the essential data
in the chain of hyperlinked resources.
With an ever increasing number of institutes oﬀering
programmatic access to their resources in the form of web
services (11), however, experiments previously conducted
manually can now be replaced by automated experiments,
capable of processing a far greater volume of data in a
systematic and explicit manner. The integration of web
services into an automated analysis pipeline or workﬂow
enables the replication of the original chain of processes
used in the traditional manual analyses. This is accom-
plished by connecting the outputs from one such service
into the input of another in a consecutive manner. By
replicating the original investigation methods in the form
of workﬂows, we are now able to pass data directly from
one service to the next without the need for any
interaction from researchers. This enables us to process
the data in a much more eﬃcient, reliable, un-biased and
explicit manner.
In this article we propose a methodology that revises the
known pathways that intersect a QTL and those derived
from a set of diﬀerentially expressed genes. This metho-
dology has been implemented systematically through the
use of web services and workﬂows and has been applied to
a use case in the mouse, Mus musculus: resistance to
African trypanosomiasis. For the purpose of implement-
ing this systematic pathway-driven approach, we have
adopted a service-based infrastructure coupled with
workﬂow technology. We chose to use the Taverna
workﬂow workbench (12) for the means of constructing
these workﬂows. This software was chosen based on
previous experience with this workbench within the
Manchester based research group. Although this work-
bench oﬀers many features for workﬂow construction, the
workﬂows discussed in this article may be constructed
using any of the well-established workﬂow workbenches
currently available. This investigation looks at the extent
to which workﬂows will be able to reduce the issues
labelled (i) to (vi) listed above, with respect to the manual
analysis of gene expression and QTL data.
African trypanosomiasis as amotivation forasystematic
approach to candidategene identification
African trypanosomiasis (sleeping sickness) is caused by
Trypanosoma spp. parasites. Human sleeping sickness is
caused by sub species of T. brucei. Trypanosomiasis of
cattle is caused by T. congolense and T. vivax, and is a
major restriction on cattle production in sub-Saharan
Africa (13). With no vaccine available, and with heavy
expenditure on trypanocidal and vector control, trypano-
somiasis is estimated to cost over 4 billion US dollars each
year in direct costs and lost production (14).
Positional cloning ofgenes controlling susceptibility to infec-
tion with T.congolense
Some breeds of African cattle, such as N’Dama, are able
to tolerate infections and remain productive (13,14). This
trait is presumed to have arisen through natural selection
acting on cattle exposed to trypanosome infection. Mice
strains also diﬀer in their resistance to T. congolense
infection; C57BL/6(B6) mice survive signiﬁcantly longer
than A/J(A) or Balb/c(C)(15,16). These mice strains act
as a model for the modes of resistance in cattle. The
diﬀerences in resistance in the mouse have been used to
map 3 QTL controlling survival after infection in the
mouse model. These loci have been designated
Trypanosoma infection response (Tir) and numbered
Tir1, Tir2 and Tir3. The Tir1 QTL showed the largest
eﬀect on survival (17), and was chosen as the proof-
of-concept target for our methodology. Tir1 is located on
mouse chromosome 17 in a particularly gene-rich area.
It is therefore possible that this QTL contains multiple
QTg—a fact that must be taken into account in any
detailed analysis of Tir1 candidate genes.
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A microarray experiment was undertaken by researchers
on the Wellcome Trust Pathogen-Host Project to
survey the mouse genome for genes and pathways that
were diﬀerentially expressed between susceptible (A/J and
Balb/c) and resistant (C57BL/6) strains. RNA samples
were prepared from liver and spleen at 0, 3, 7, 9 and 17
days post-infection and from kidney at Days 0 and 7 post-
infection. Twenty-ﬁve tissue samples were collected, each
condition being a unique combination of day, tissue and
strain. The RNA prepared from these samples was
combined to create ﬁve independent pools of ﬁve RNA
samples for each condition, and was subsequently
hybridized to Aﬀymetrix (18) Mouse430_2 gene chips.
A total of 180 microarrays were used to measure the
expression of the 36 conditions that were studied.
Microarray data was ﬁrst analysed with DChip (19) to
determine any outliers. All hybridizations that passed the
DChip analysis were normalized using RMA (20). In
addition, PCA analysis was performed to identify any
hybridizations that passed the DChip quality control but
could still be classiﬁed as outliers.
Manual analysis of theMouse–Cow syntenousregion
Ten QTL for response to T. congolense infection have also
been mapped in cattle (14). The comparison of the cattle
and mouse QTL identiﬁed a 400kb sub-region of the Tir1
mouse QTL that was syntenic with a QTL on bovine
chromosome 7, spanning from  31.8 to 32.2Mb on
mouse chromosome 17.
It was hypothesized that the mouse and cattle QTL
might both contain the same QTL genes; consequently this
region, which contained just 8 of the 344 genes in the
murine QTL, was prioritized for intensive research using
the traditional manual methods. Another candidate gene
chosen for further study was tumour necrosis factor
(TNF). This was chosen as it lay within the Tir1 region
and is known to be a key gene for control of immune
response. Detailed experiments using TNF knock-out
mice, however, seemed to demonstrate that TNF was not
playing a key role in determining the resistant susceptible
phenotypes (21). We therefore explored the hypothesis
that a large-scale, systematic and data-driven approach
could uncover other candidate quantitative trait genes that
would be missed through targeted, hypothesis-driven
strategies. Although the mouse and cattle regions do
share syntenous regions, there is no expectation that the
murine and bovine QTL will contain the same genes.
MATERIALS AND METHODS
The expression of genes within their biological pathways
contributes to the expression of an observed phenotype. By
investigating links between genotype and phenotype at the
level of biological pathways, it is possible to obtain a global
view of the processes which may contribute to the
expression of the phenotype (22). Additionally, the explicit
identiﬁcation of responding pathways naturally leads to
experimental veriﬁcation in the laboratory. We therefore
optedtoanalyseQTLandgeneexpressiondatanotdirectly
atthelevelofgenesbutatthelevelofpathways(Figure1a).
Using this pathway-driven approach provides a driving
force for functional discovery rather than gene discovery.
In order to determine which genes reside in the QTL
region of choice, the physical boundaries of the QTL need
to be determined. Each gene is then subsequently
annotated with its associated biological pathways,
obtained from the KEGG pathway database (23). The
same process of pathway annotation is also carried out for
the genes that are found to be diﬀerentially expressed in
the microarray study of choice. These two sets of pathway
data enable us to obtain a subset of common pathways
that contain genes within the QTL region and genes that
are diﬀerentially expressed in the microarray study. By
identifying those pathways common to both microarray
and QTL data, we are able to obtain a much richer model
of the processes which may be inﬂuencing the expression
of the phenotype. This process is summarized in
Figure 1b.
One drawback of this approach, however, is the reliance
on extant pathway annotations for genes identiﬁed in the
QTL regions and from the microarray studies. However,
by explicitly recording the workﬂow output from KEGG,
we can, if required, identify genes that do not have
pathways associated with them.
For such an approach to be conducted systematically,
any web resources used (including their parameters)
should be stated explicitly. By passing data from one
service to the next in a workﬂow, vast amounts of data can
be analysed with little input required from the user, other
than that of parameter conﬁguration. This makes work-
ﬂow technology an ideal tool for processing high-
throughput data in a systematic and explicit manner.
In order to determine the genes that lie within Tir1 QTL
region, the position of ﬂanking markers used in the
original mapping studies were identiﬁed in mouse
Ensembl (24) release 40. These were identiﬁed as
D17Mit29 and D17Mit11 on chromosome 17 (16), at
28394586 and 38278830bp respectively, within version
40 of the Ensembl Mouse database (NCBI build 36).
The position of D17Mit11 was estimated based on
close proximity to the gene Crisp2 (Mouse Genome
Identiﬁer - MGI:98815).
The implementation of the pathway-driven approach
consisted of three Taverna workﬂows. The ﬁrst workﬂow
constructed, qtl_pathway, was implemented to identify
genes within a QTL region, and subsequently map them to
pathways held in the KEGG pathway database. Lists of
genes within a QTL were obtained from Ensembl, together
with UniProt (25) and Entrez gene (26) identiﬁers,
enabling them to be cross-referenced to KEGG gene and
pathway identiﬁers. A fragment of this workﬂow can be
seen in Figure 2, which shows the mapping from QTL
region (label A) to KEGG gene identiﬁers (label C). This
workﬂow represents an automated version of the manual
methods required to perform such a task, including the
process of collating all information into single output ﬁles.
Additional services were added to format data into the
correct input/output style, these services have not been
assigned labels in Figure 2.
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Figure 1. (a) An illustration showing the prioritization of phenotype candidates, from the pathway-driven approach. All pathways are diﬀerentially
expressed in the microarray data. Those pathways which contain genes from the QTL region are assigned a higher priority (pathways A and B) than
those with no link to the QTL region (pathway C). Higher priority pathways are then ranked according to their involvement in the phenotypes
expression, based on literature evidence. Abbreviations: CHR:Chromosome; QTL:Quantitative Trait Loci. (b) An illustration for the pathway-driven
approach to genotype–phenotype correlations. The process of annotating candidate genes from microarray and QTL investigations with their
biological pathways is shown. The pathways gathered from both studies are compared and those common to both are extracted as the candidate
pathways for further analysis.These pathways represent a set of hypotheses, in that the candidates are the hypothetical processes which may
contribute to the expression of the observed phenotype. Subsequent veriﬁcation is required for each pathway by wet lab investigation and literature
searches. This apporach is separated into two sections, distinguished by the dividing line between the selction of common pathways and the
generation of hypotheses. The section labelled A represents the workﬂow side of the investigation;, whilst the section labelled B represents veriﬁcation
of the hypotheses through wet lab experimentation and literature mining.
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and A/J mice at Days 3 and 7 post-infection, identiﬁed 981
and 1331 probesets that were diﬀerentially expressed on
the basis of a corrected t-test with a p-value <0.01 and a
log2 fold change >0.5. We chose to focus on the early time
points of Days 3 and 7 for this investigation. This was
because the mouse strains used in microarray study
showed a strong gene expression response to infection at
the early time points in the microarray data compared to
that of the later time points. The later time points from the
microarray study were found to be the result of secondary
eﬀects on infection. Permissive criteria were used at this
stage of data analysis in order to reduce the incidence of
false negative results (which could result in missing one of
the true QTg). Any true negative results would later be
discarded on correlation of the pathways with the
observed phenotype. These correlations of pathways
with the observed phenotype are carried out through
traditional in vivo and in vitro analyses on the candidate
QTg. Mining the literature for involvement of the path-
ways and candidate genes being involved in the expression
of the phenotype are also required for hypothesis
veriﬁcation. As a result of permissive criteria being
employed, 2312 probesets were chosen for further analysis
and annotation with their biological pathways.
The second workﬂow, Probeset_to_pathway, provided
annotation of microarray probeset identiﬁers. Ensembl
gene identiﬁers associated with Aﬀymetrix probesets were
obtained from Ensembl. These genes were entered into the
same annotation workﬂow as that used for qtl_pathway.
The Entrez and UniProt database identiﬁers were used to
map the Aﬀymetrix probeset identiﬁers to KEGG
pathways.
Signiﬁcant problems were encountered when attempting
to cross-reference between database identiﬁers. This has
proven to be a considerable barrier in bioinformatics
involving distributed resources, including the naming
conventions assigned to biological objects (27). In an
attempt to resolve this, we have provided a single and
explicit methodology by which this cross-referencing was
done. This methodology is captured within the workﬂows
themselves.
To obtain the pathways which both intersect the QTL
region and are present in the gene expression data, we
used a third workﬂow, named common_pathways,t o
obtain a list of KEGG pathway descriptions. Each of
the pathways returned from the common_pathways work-
ﬂow were investigated in turn. Lists of intersecting QTL
and microarray pathway outputs used in this study are
available as Supplementary Data.
Details of gene sequencing methods, carried out for
validating potential candidate QT genes, are also provided
in the Supplementary Data (Supplementary Table 2 and
sequencing_methods). Any additional information is
available on request.
Microarray data used in this investigation is available in
ArrayExpress (E-MEXP-1190).
RESULTS AND DISCUSSION
Candidategenes involvedin trypanosomiasis resistance
The systematic application of the workﬂows to the lists
of genes, from both the Tir1 QTL region and
the microarray study, identiﬁed a total of 87 pathways
from both Days 3 and 7 post-infection which contained
genes in both the QTL and the set of diﬀerentially
regulated genes (available in Supplementary Data named
Tir1_DayX_intersecting_pathways.xls, where X represents
the day post-infection). Of the 344 genes identiﬁed in the
Tir1 QTL region, a total of 82 were subsequently mapped
to their KEGG biological pathways.
Table 1 shows the set of candidate pathways and QT
genes that may be involved in the trypanosomiasis
resistance phenotype. From this list it is clear that the
complete list of 344 genes, initially identiﬁed in the Tir1
QTL region, has been narrowed down signiﬁcantly to just
Figure 2. Annotation workﬂow to gather genes in a QTL region, and
provide information on the pathways involved with a phenotype. This
workﬂow, shown as a sub-set of the complete workﬂow, requires
a chromosome, and QTL start and stop positions in base pairs. The
genes in this QTL region are then returned from Ensembl via a
BioMart plug-in. These genes are subsequently annotated with UniProt
and Entrez identiﬁers, start and end positions, Ensembl Transcript ids
and Aﬀymetrix probeset identiﬁers for the chips Mouse430_2 and
Mouse430a_2. The UniProt and Entrez ids are submitted to the KEGG
gene database, retrieving a list of KEGG gene ids.
Nucleic Acids Research, 2007, Vol. 35, No. 16 562932 candidate QT genes. A number of genes identiﬁed from
these results, are present in multiple pathways from the 87
pathways identiﬁed in total. In order to determine the role
of each QTg, each of the pathways was associated with the
gene expression data using the GenMapp software
package (28). Those pathways in which a high proportion
of component genes showed diﬀerential expression follow-
ing trypanosome challenge were prioritized for further
analysis. One such pathway identiﬁed was the MapK
signalling pathway.
There are four genes from the MapK pathway within
the Tir1 QTL: Daxx, TNF, Mapk13 and Map14. Of these,
Daxx showed the strongest signal of diﬀerential expression
at early time points. (Figure 4 in Supplementary Data)
and TNF has already been shown to be a poor candidate
QTg (29). Daxx was therefore chosen as the primary
candidate QTg, from this pathway, to investigate further.
Daxx is widely reported to be an enhancer for apoptosis
(30,31). It is also reported that susceptible mice infected
with trypanosomiasis show an increase in apoptosis (32).
During the acute stage of trypanosome infection, a large
number of leucocytes undergo apoptosis, as the immune
response is re-modelled to control the infection (33). This
pathway is therefore an example of the pathway labelled A
in Figure 1a, with the candidate gene being directly related
to the QTL region and known, through literature, to be
involved in the phenotype.
The identiﬁcation of Daxx as a candidate for the Tir1
QTL gene prompted the re-sequencing of this gene in
order to identify polymorphisms that might correlate
with the phenotype. Out of the 17 polymorphisms
identiﬁed, 3 were found to have allele distributions that
show a relationship with the phenotype. Two of these
three were located in the intronic or 50 upstream region
suggesting a possible aﬀect on splicing or expression. The
third mutation to associate with survival time was a three
base deletion in exon 5, coding for an aspartic acid
[in submission to dbSNP (34)]. This deletion of one
aspartic acid residue (D) in a poly-aspartic acid tract was
identiﬁed in BALB/c and A/J whereas no deletion was
found the tolerant strain C57BL/6J (Figure 3). It has been
previously noted that Daxx binds to the p53 protein via
this acidic region (35). The study by Zhao et al. (35)
showed that the deletion of this acidic region abolished the
Daxx–p53 interaction. The protein p53 is reported to
control cellular apoptosis (35,36). We therefore hypothe-
size that a mutation within this acidic region may alter the
binding between Daxx and p53 in such a way as to result
in a diﬀering apoptosis phenotype between the mouse
strains. In order to conﬁrm this eﬀect, however, further
in vitro and in vivo studies are required. Further
investigation is also required to conﬁrm the presence of
the Daxx gene within the bovine QTL region, and its role
as a potential QTg.
Table 1. A subset of the KEGG pathways found to be diﬀerentially expressed at Day 7 in the microarray data
KEGG pathway Ids Pathway descriptions Genes in Tir1 QTL region
path:mmu00240 Pyrimidine metabolism—Mus musculus (mouse) Znrd1
path:mmu04610 Complement and coagulation cascades—Mus musculus (mouse) C4b C2 Cfb
path:mmu04320 Dorso-ventral axis formation—Mus musculus (mouse) Notch3 Notch4
path:mmu00620 Pyruvate metabolism—Mus musculus (mouse) Glo1
path:mmu00600 Sphingolipid metabolism—Mus musculus (mouse) Neu1
path:mmu04370 VEGF signalling pathway—Mus musculus (mouse) Mapk14 Mapk13
path:mmu04540 Gap junction—Mus musculus (mouse) Tubb5
path:mmu00565 Ether lipid metabolism—Mus musculus (mouse) Agpat1
path:mmu00564 Glycerophospholipid metabolism—Mus musculus (mouse) Agpat1
path:mmu04310 Wnt signalling pathway—Mus musculus (mouse) Csnk2b
path:mmu00590 Arachidonic acid metabolism—Mus musculus (mouse) Cyp4f14 Cyp4f15 Cyp4f13 Cyp4f16
path:mmu04620 Toll-like receptor signalling pathway—Mus musculus (mouse) Mapk14 Tnf Mapk13
path:mmu04912 GnRH signalling pathway—Mus musculus (mouse) Mapk13 Mapk14
path:mmu04670 Leukocyte transendothelial migration—Mus musculus (mouse) Mapk13 Mapk14
path:mmu04330 Notch signalling pathway—Mus musculus (mouse) Notch3 Notch4
path:mmu04110 Cell cycle—Mus musculus (mouse) Cdkn1a
path:mmu00561 Glycerolipid metabolism—Mus musculus (mouse) Agpat1
path:mmu04530 Tight junction—Mus musculus (mouse) Csnk2b
path:mmu04510 Focal adhesion—Mus musculus (mouse) Col11a2 Tnxb
path:mmu04010 MAPK signalling pathway—Mus musculus (mouse) Mapk14 Tnf Daxx Mapk13
path:mmu00062 Fatty acid elongation in mitochondria—Mus musculus (mouse) Ppt2
path:mmu04664 Fc epsilon RI signalling pathway—Mus musculus (mouse) Mapk14 Tnf Mapk13
path:mmu00310 Lysine degradation—Mus musculus (mouse) Ehmt2
path:mmu04630 Jak-STAT signalling pathway—Mus musculus (mouse) Pim1
path:mmu00230 Purine metabolism—Mus musculus (mouse) Pde9a Znrd1
path:mmu04910 Insulin signalling pathway—Mus musculus (mouse) Flot1
path:mmu03320 PPAR signalling pathway—Mus musculus (mouse) Rxrb Angptl4
path:mmu00260 Glycine, serine and threonine metabolism—Mus musculus (mouse) Cbs
path:mmu00604 Glycosphingolipid biosynthesis - ganglioseries—Mus musculus (mouse) B3galt4
path:mmu04520 Adherens junction—Mus musculus (mouse) Csnk2b
path:mmu04920 Adipocytokine signalling pathway—Mus musculus (mouse) Rxrb Tnf
The genes listed above that appear in the diﬀerentially expressed pathways are also located within the Tir1 QTL region. We have chosen to ignore
the pathways containing the H2 complex genes due to the highly polymorphic nature of these genes. Pathways that do not represent metabolic
processes have also been removed from this table. A complete list of the genes and pathways common to the Tir1 QTL region and Day 7 gene
expression data can be found within the Supplementary Data.
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workﬂows are currently undergoing further investigation
to establish their precise role in the trypanosomiasis
phenotype.
Workflows andthe systematic approach
Since we have chosen to automatically pass data from one
service into the next using workﬂows, we are now able to
process a far greater volume of information than can be
achieved using manual analysis. This in turn provides the
opportunity to systematically analyse any results we
obtain without the need to prematurely ﬁlter the data
for human convenience. An example of this triaging
process was found, where studies carried out by research-
ers on the Wellcome Trust Pathogen-Host Project (see
Acknowledgements section) had failed to identify Daxx as
a candidate gene for trypanosomiasis resistance. This
occurred when manually analysing the microarray and
QTL data; researchers hypothesized that the mouse–cow
syntenous QTL region may contain the same QT genes. It
was later found through a systematic analysis that Daxx
lay outside of this region, and so the mouse QTL data was
prematurely ﬁltered based on researcher bias (although
this does not preclude the discovery of other QT genes
within this syntenous region).
A note should be made in relation to the SNP density of
this QTL region, and the possibility of further QTg within
this region. Of the 344 genes identiﬁed within the QTL
region, 194 were found to contain SNPs, of which 144
exhibit expression diﬀerences that correlate with pheno-
type. These 144 genes could therefore be candidate QT
genes. Polymorphisms in individual genes in the QTL are
insuﬃciently informative to reduce the list of candidate
genes to a manageable number. The use of a workﬂow-
based approach, however, makes it possible to prioritize
those genes that have a functional association with
pathways, and have been shown to respond to infection
out of the initial list of candidate genes. It should be
emphasized that whilst we have identiﬁed a correlation
between a new polymorphism in Daxx and a pathway that
responds to infection, we cannot yet conclude that this is
the QTg. The Tir1 QTL is linked to survival after
infection, whilst the correlation we propose is between a
DNA polymorphism and gene expression. The poly-
morphism identiﬁed may result in changes of the gene
expression, but not the diﬀerences in survival of the mouse
strains used. Detailed functional studies of the Daxx–p53
interaction will be required to determine the eﬀect, if any,
the aspartate deletion plays in relation to the observed
phenotype.
The use of a hypothesis-driven approach is essential for
the construction of a scientiﬁcally sound investigation,
however, the use of a data-driven approach should also be
considered. This would allow the experimental data to
evolve in parallel to a given hypothesis to form its own
hypotheses regardless of any previous assumptions (8), as
shown by this case. This method can be used to either
conﬁrm or disprove any given hypotheses, compiled by a
traditional hypothesis-driven analysis of the data. As such,
we propose the use of a combined data and hypothesis-
driven analyses of the experimental data.
Worthy of note is that the expression of genes and their
subsequent pathways can be investigated with little to no
prior knowledge, other than that of the selection of all
candidate genes from the entire QTL region. This reduces
the bias which may be encountered from traditional
hypothesis/expert-driven approaches. By implementing
the manually conducted experiments in the form of
workﬂows, we have shown that an automated systematic
approach reduces, if not eliminates, these biases whilst
providing an explicit methodology for recording the
processes involved. These explicit analysis pipelines
increases the reproducibility of our methods and also
provides a framework for which future experiments can
adapt or update the underlying methods.
In using the Taverna workﬂow workbench, we are able
to state the services used and the parameters chosen at
execution time. Specifying the processes in which these
services interact with one another in the native Taverna
workﬂow language, Scuﬂ (12), enables researchers to re-
use and re-run previously conducted experiments. An
additional feature of the Taverna system is the capture of
experimental provenance. The workﬂow parameters and
individual results are captured in this execution log where
the data obtained from previous analyses can be viewed.
The generality of these workﬂows allows them to be re-
used for the integration of mapping and microarray data
in other cases other than that of trypanosomiasis
response. Furthermore, the QTL gene annotation work-
ﬂow may be utilized in projects, which use the mouse
model organism and do not have any gene expression data
to back up ﬁndings. Likewise, the microarray gene
annotation workﬂow may be used in studies with no
quantitative evidence for the observed phenotype. Future
work on this use case, investigating response to trypano-
somiasis infection, will include analysis of the two
remaining QTL regions, Tir2 and Tir3 (a, b and c), and
the integration of cattle QTL and gene expression data.
It should be noted that an unavoidable ascertainment
bias is introduced into the methodology, in the form of
utilizing remote resources for candidate selection. This
bias was observed on analysis of the Tir1 region, where a
total of 344 unique candidate QT genes were identiﬁed
from BioMart, of which 82 genes were annotated with
their biological pathways. The lack of pathway annota-
tions limits the ability to narrow down the true candidate
genes from the total genes identiﬁed in the QTL region,
with the reliance on extant knowledge. A rapid increase in
the number of genes annotated with their pathways,
however, means that the number of candidate QTg
identiﬁed in subsequent analyses is sure to increase. The
workﬂows described here provide the means to readily
repeat the analysis.
Figure 3. Alignment of part of the acidic region of the Daxx gene in
which an aspartate was deleted. 35/41 amino acids in this region are
aspartic acid (D) or glutamic acid (E).
Nucleic Acids Research, 2007, Vol. 35, No. 16 5631Although we have successfully reduced the number of
false negative QTg, one possible complication we envisage
is the increase in the number of false positive candidate
QTg returned to the user.
The KEGG pathway database was chosen as the
primary source of pathway information due it being
publicly available and containing a large set of biological
pathway annotations. This results in a bias, relying on
extant knowledge from a single data repository; however,
this investigation was established as a proof of concept for
the proposed methodology and, with further work, may
be modiﬁed to query any number of pathway databases,
provided they oﬀer web service functionality.
CONCLUSION
In this investigation, we have illustrated how the large-
scale analysis of microarray gene expression and quanti-
tative trait data, investigated at the level of biological
pathways, enables links between genotype and phenotype
to be successfully established. This was implemented
systematically through the use of workﬂows. Our inves-
tigation conﬁrmed that non-systematic manual examina-
tion of QTL and microarray data does introduce bias into
the processes, particularly by discarding candidates in
premature ﬁltering of such large datasets.
Analysis of the QTL and gene expression data collected
under the Wellcome Trust Host-Pathogen project identi-
ﬁedacandidategene,Daxx,whichisthoughttobestrongly
associated with resistance to trypanosomiasis infection.
The workﬂows developed in this project are freely
available for re-use—either by ourselves or others in
future analyses and have been integrated into the
myExperiment (37) project which supports scientiﬁc
collaboration, discovery and workﬂow re-use.
Revisiting the issues (i) to (vi) outlined within the
Introduction section, we can show that by utilizing
workﬂows within this investigation we have:
(i) Successfully reduced the premature ﬁltering of
datasets, where we are now able to process all
data systematically through the workﬂows
(ii) The systematic analysis of the gene expression and
QTL data has supported a data-driven analysis
approach
(iii) The use of a data-driven approach has enabled a
number of novel hypotheses to be inferred from the
workﬂow results, including the role of apoptosis
and Daxx in trypanosomiasis resistance
(iv) The workﬂows have explicitly captured the data
analysis methodologies used in this investigation
(v) Capturing these data analysis methods enables for
the direct re-use of the workﬂows in subsequent
investigations
(vi) The total number of errors within this investigation
has been reduced as a whole from all of the issues
addressed above
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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